Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Relation between Human Epididymis Protein 4 and Endometrial Pathology in Women with Postmenopausal Bleeding


Affiliations
1 Department of Obstetrics & Gynecology, Faculty of Medicine, Cairo University, Egypt
2 Department of Pathology Cairo University, Cairo, Egypt
3 Department of Clinical Pathology Cairo University, Cairo, Egypt
     

   Subscribe/Renew Journal


Objective: To evaluate the value of human epididymis protein 4 (HE4) in predicting endometrial pathology in women with postmenopausal bleeding (PMB). Method: A cohort study included 100 women with PMB. Women with endometrial thickness (ET) >5mm were subjected to hysteroscopic guided fractional curettage (FC) followed by total abdominal hysterectomy and bilateral salpingo-oophorectomy with or without pelvic lymphadenectomy. After exclusion of 10 patients, the value of serum HE4 was tested in 90 patients for the ability to predict endometrial pathology based on hysterectomy specimen. Results: Level of HE4 showed a significant difference among women with different endometrial pathologies. HE4 showed a significant positive correlation with the severity of the endometrial lesion, with mean values of 38.33±27 pmol/L for atrophic endometrium (11 cases), 51.26±28.59 pmol/L for simple endometrial hyperplasia (SEH,51 cases), 148.4 ±67.34 pmol/L for atypical endometrial hyperplasia (AEH,16 cases) and 390.9±351.72 pmol/L for endometrial carcinoma (EC,12 cases) Using the cut-off value of 69.5 pmol/L for preoperative HE4 yielded a sensitivity of 75% and a specificity of 88.5% in prediction of EC. Conclusion: HE4 can predict endometrial pathology in women with PMB with a high specificity and a fair sensitivity.

Keywords

Human epididymis protien4 (HE4); postmenopausal bleeding; endometrial carcinoma; endometrial pathology.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 102

PDF Views: 0




  • Relation between Human Epididymis Protein 4 and Endometrial Pathology in Women with Postmenopausal Bleeding

Abstract Views: 102  |  PDF Views: 0

Authors

Ahmed L Aboul Nasr
Department of Obstetrics & Gynecology, Faculty of Medicine, Cairo University, Egypt
Ghada A AbdelMoety
Department of Obstetrics & Gynecology, Faculty of Medicine, Cairo University, Egypt
Mostafa S. Salem
Department of Pathology Cairo University, Cairo, Egypt
Marwa M Elsharkawy
Department of Clinical Pathology Cairo University, Cairo, Egypt
Nada Kamal
Department of Obstetrics & Gynecology, Faculty of Medicine, Cairo University, Egypt
Ahmed M Maged
, Egypt

Abstract


Objective: To evaluate the value of human epididymis protein 4 (HE4) in predicting endometrial pathology in women with postmenopausal bleeding (PMB). Method: A cohort study included 100 women with PMB. Women with endometrial thickness (ET) >5mm were subjected to hysteroscopic guided fractional curettage (FC) followed by total abdominal hysterectomy and bilateral salpingo-oophorectomy with or without pelvic lymphadenectomy. After exclusion of 10 patients, the value of serum HE4 was tested in 90 patients for the ability to predict endometrial pathology based on hysterectomy specimen. Results: Level of HE4 showed a significant difference among women with different endometrial pathologies. HE4 showed a significant positive correlation with the severity of the endometrial lesion, with mean values of 38.33±27 pmol/L for atrophic endometrium (11 cases), 51.26±28.59 pmol/L for simple endometrial hyperplasia (SEH,51 cases), 148.4 ±67.34 pmol/L for atypical endometrial hyperplasia (AEH,16 cases) and 390.9±351.72 pmol/L for endometrial carcinoma (EC,12 cases) Using the cut-off value of 69.5 pmol/L for preoperative HE4 yielded a sensitivity of 75% and a specificity of 88.5% in prediction of EC. Conclusion: HE4 can predict endometrial pathology in women with PMB with a high specificity and a fair sensitivity.

Keywords


Human epididymis protien4 (HE4); postmenopausal bleeding; endometrial carcinoma; endometrial pathology.



DOI: https://doi.org/10.37506/v11%2Fi2%2F2020%2Fijphrd%2F194948